Evidence map›Paper›PMID 34680254›Full record

ArticleCancers2021

Analysis of Post-Colonoscopy Colorectal Cancer and Its Subtypes in a Screening Programme.

Saloa Unanue-Arza, Isabel Idigoras-Rubio, Maria Jose Fernández-Landa, Isabel Bilbao-Iturribarria, Luis Bujanda, Isabel Portillo

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Saloa Unanue-ArzaDepartment of Nursing I, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0003-0918-5980
Isabel Idigoras-RubioOsakidetza Basque Health Service, Basque Country Colorectal Screening Programme, 48011 Bilbao, Spain.
Maria Jose Fernández-LandaOsakidetza Basque Health Service, OSI Bilbao-Basurto, Rekalde Ambulatory, 48002 Bilbao, Spain.
Isabel Bilbao-IturribarriaOsakidetza Basque Health Service, Basque Country Colorectal Screening Programme, 48011 Bilbao, Spain.
Luis BujandaBiodonostia Health Research Institute, 20014 San Sebastian, Spain.
Isabel PortilloOsakidetza Basque Health Service, Basque Country Colorectal Screening Programme, 48011 Bilbao, Spain.ORCID 0000-0002-3871-3423

Funding

Basque Government IT1294-19
6 · The paper itself

Abstract

Using the algorithm of the World Endoscopy Organisation (WEO), we have studied retrospectively all colorectal cancers, both detected and non-detected by the Basque Country screening programme from 2009 to 2017. In the screening programme 61,335 colonoscopies were performed following a positive Faecal Immunochemical test (FIT) (≥20 µg Hb/g faeces) and the 128 cases of post-colonoscopy colorectal cancer (PCCRC) detected were analysed. Among them, 50 interval type PCCRCs were diagnosed (before the recommended surveillance), 0.8 cases per 1000 colonoscopies performed, and 78 non-interval type PCCRCs (in the surveillance carried out at the recommended time or delayed), 1.3 per 1000 colonoscopies. Among the non-interval type PCCRCs, 61 cases were detected in the surveillance carried out at the recommended time (type A) and 17 when the surveillance was delayed (type B), 1 case per 1000 colonoscopies performed and 0.28 cases per 1000 colonoscopies performed, respectively. Interval type PCCRC is less frequent than non-interval type PCCRC. In interval type PCCRCs, CRCs detected in advanced stages (stages III-IV) were significantly more frequent than those detected in early stages, compared to those of non-interval type PCCRCs (OR = 3.057; 95% CI, 1.410-6.625;

Indexed as

adverse effectscolonoscopycolorectal neoplasmsearly detection of cancerinterval cancerrisk factors

Identifiers

PMID34680254
PMCPMC8533900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.